Autres langues Ibnsina Pharma

Actions

ISPH

EGS512O1C012

Cours en clôture Egyptian Exchange Autres places de cotation 00:00:00 30/04/2024			Varia. 5j.	Varia. 1 janv.
2,37 ^EGP	-7,06 %		-18,28 %	-24,52 %

03/03	Ibnsina Pharma annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI
2023	Ibnsina Pharma annonce ses résultats pour le troisième trimestre et les neuf mois terminés le 30 septembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023	03/03
Ibnsina Pharma(CASE:ISPH) added to EGX 30 Index	05/02
Ibnsina Pharma Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Ibnsina Pharma Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	13/08/23
Ibnsina Pharma(CASE:ISPH) dropped from EGX 30 Index	02/08/23
Ibnsina Pharma Reports Earnings Results for the First Quarter Ended March 31, 2023	23/05/23
Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2022	01/03/23
Ibnsina Pharma Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/11/22
Ibnsina Pharma(CASE:ISPH) dropped from S&P Global BMI Index	19/09/22
Ibnsina Pharma Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	14/08/22
Ibnsina Pharma Reports Earnings Results for the First Quarter Ended March 31, 2022	22/05/22
Ibn Sina Pharma Company (S.A.E) acquired El Shorouk Hospital for EGP 430 million.	22/05/22
Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2021	23/03/22
Ibnsina Pharma Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	14/11/21
Ibn Sina Pharma Company (S.A.E.) Announces Consolidated Earnings Results for the Six Months Ended June 30, 2021	16/08/21
Ibnsina Pharma Reports Consolidated and Standalone Earnings Results for the First Quarter of 2021	01/06/21
Ibnsina Pharma Announces Board Changes	04/04/21
Ibnsina Pharma Appoints Mohamed Mohsen Mohamed Mahgoub as CEO	04/04/21
Ibnsina Pharma Reports Earnings Results for the Full Year 2020	04/04/21
Ibn Sina Pharma (S.A.E) Announces Audited Standalone Earnings Results for the Full Year Ended December 31, 2020	01/03/21

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Ibnsina Pharma

Actions

ISPH

EGS512O1C012

Autres langues

Filtres